CD59 and neoplasm: Numerous studies have demonstrated the deleterious effect of CD59 expression on hindering antibody-based cancer immunotherapy;33,34 however, a limited reports about the effect of CD59 on chemotherapy, which revealed that CD59 insufficiency sensitizes tumor cells to chemotherapy, likely due to the resultant pro-apoptotic effect44,45.